Design and synthesis of bivalent yohimbine derivatives as potential subtype-selective α2-adrenergic receptor agents

被引:0
|
作者
Zheng, WP
Sun, GP
Lei, LP
Feller, DR
Miller, DD
机构
[1] Univ Tennessee, Dept Pharmaceut Sci, Memphis, TN 38163 USA
[2] Univ Mississippi, Dept Pharmacol, University, MS 38677 USA
[3] Univ Mississippi, Natl Ctr Dev Nat Prod, Sch Pharm, University, MS 38677 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
113-MEDI
引用
收藏
页码:U1188 / U1188
页数:1
相关论文
共 50 条
  • [21] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL AMIDINE DERIVATIVES AS MUSCARINIC RECEPTOR SUBTYPE-SELECTIVE AGONISTS
    OJO, B
    DUNBAR, PG
    DURANT, GJ
    HUZL, JJ
    ELASSADI, AA
    PERIYASAMY, S
    NGUR, DO
    HOSS, WP
    MESSER, WS
    LIFE SCIENCES, 1995, 56 (11-12) : 1005 - 1005
  • [22] Physiological significance of α2-adrenergic receptor subtype diversity:: one receptor is not enough
    Philipp, M
    Brede, M
    Hein, L
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 283 (02) : R287 - R295
  • [23] Design, synthesis, and functional assessment of Cmpd-15 derivatives as negative allosteric modulators for the β2-adrenergic receptor
    Meng, Kaicheng
    Shim, Paul
    Wang, Qingtin
    Zhao, Shuai
    Gu, Ting
    Kahsai, Alem W.
    Ahn, Seungkirl
    Chen, Xin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (09) : 2320 - 2330
  • [24] An investigation of the uroselective properties of four novel α1a-adrenergic receptor subtype-selective antagonists
    Pulito, VL
    Li, XB
    Varga, SS
    Mulcahy, LS
    Clark, KS
    Halbert, SA
    Reitz, AB
    Murray, WV
    Jolliffe, LK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (01): : 224 - 229
  • [25] Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders
    Ye, Na
    Neumeyer, John L.
    Baldessarini, Ross J.
    Zhen, Xuechu
    Zhang, Ao
    CHEMICAL REVIEWS, 2013, 113 : PR123 - PR177
  • [26] FUNCTION OF BRAIN α2B-ADRENERGIC RECEPTOR CHARACTERIZED WITH SUBTYPE-SELECTIVE α2B ANTAGONIST AND KO MICE
    Luhrs, Lauren
    Manlapaz, Cynthia
    Kedzie, Karen
    Rao, Sandhya
    Cabrera-Ghayouri, Sara
    Donello, John
    Gil, Daniel
    NEUROSCIENCE, 2016, 339 : 608 - 621
  • [27] Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide
    Sano, H
    Noguchi, T
    Tanatani, A
    Hashimoto, Y
    Miyachi, H
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (09) : 3079 - 3091
  • [28] Therapeutic potential of non-competitive, subtype-selective metabotropic glutamate receptor ligands
    Mutel, V
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (12) : 1845 - 1852
  • [29] BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTORS DISPLAY SUBTYPE-SELECTIVE COUPLING TO GS
    GREEN, SA
    HOLT, BD
    LIGGETT, SB
    MOLECULAR PHARMACOLOGY, 1992, 41 (05) : 889 - 893
  • [30] α-2-adrenergic receptor subtype alterations in the brainstem in the sudden infant death syndrome
    Ozawa, Y
    Takashima, S
    Tada, H
    EARLY HUMAN DEVELOPMENT, 2003, 75 : S129 - S138